POLYGYNAX

This brand name is authorized in Cyprus, Ecuador, Estonia, France, Hong Kong, Croatia, Lithuania, Malta, Mexico, Nigeria, Romania, Singapore, Tunisia

Active ingredients

The drug POLYGYNAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Neomycin UNII 057Y626693 - NEOMYCIN SULFATE

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. Read about Neomycin

2 Polymyxin B UNII 19371312D4 - POLYMYXIN B SULFATE

Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane. Read about Polymyxin B

3 Nystatin UNII BDF1O1C72E - NYSTATIN

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans. Read about Nystatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
POLYGYNAX Vaginal capsule		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G01AA51	Nystatin, combinations	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.011-10-04
Country: EE	Ravimiamet	Identifier(s): 1127001, 1128181
Country: FR	Base de données publique des médicaments	Identifier(s): 66085108, 68739115
Country: HK	Department of Health Drug Office	Identifier(s): 29091
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-155352773
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006309, 1014582, 1073846, 1079847, 1083704, 1085845, 1086395, 1092801
Country: MT	Medicines Authority	Identifier(s): MA093/00401
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 081M2004
Country: NG	Registered Drug Product Database	Identifier(s): 04-3009
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W01949002, W64599001
Country: SG	Health Sciences Authority	Identifier(s): 07745P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1763031